224 results on '"Robinson, Christina M."'
Search Results
2. Endoscopist adenomas-per-colonoscopy detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry
3. Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability
4. What do ‘false-positive’ stool tests really mean? Data from the New Hampshire colonoscopy registry
5. Targeted multicolor in vivo imaging over 1,000 nm enabled by nonamethine cyanines
6. Association of endoscopist colonoscopy quality measures with follow-up colonoscopy outcomes after positive stool tests (mt-sDNA or FIT): Retrospective cross-sectional analysis of data from the New Hampshire Colonoscopy Registry
7. Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum-based chemotherapy
8. Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum-based chemotherapy
9. Young adults and metachronous neoplasia: risks for future advanced adenomas and large serrated polyps compared with older adults
10. Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum‐based chemotherapy
11. Endoscopist Adenoma Per Colonoscopy Detection Rates and Risk for Post Colonoscopy Colorectal Cancer: Data From New Hampshire Colonoscopy Registry
12. Higher Serrated Polyp Detection Rates Are Associated With Lower Risk of Postcolonoscopy Colorectal Cancer: Data From the New Hampshire Colonoscopy Registry
13. Data from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
14. Supplementary Figure S1-S10 from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
15. Supplementary Table 1 from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
16. Supplementary Material and Methods from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
17. Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry
18. Using New Hampshire Colonoscopy Registry data to assess United States and European post-polypectomy surveillance guidelines
19. Supplementary Table from Colonoscopy Findings in FIT+ and mt-sDNA+ Patients versus in Colonoscopy-only Patients: New Hampshire Colonoscopy Registry Data
20. Data from Colonoscopy Findings in FIT+ and mt-sDNA+ Patients versus in Colonoscopy-only Patients: New Hampshire Colonoscopy Registry Data
21. Supplementary Methods from TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin
22. Supplementary Tables from TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin
23. Data from Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma
24. Supplementary Figure S8.1 from TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin
25. Supplementary Movie 1 from TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin
26. Data from TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin
27. Supplementary Figures from TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin
28. Supplementary Data from Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma
29. Supplementary Figure S2 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
30. Supplementary Data File S5 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
31. Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
32. Response
33. Impact of Colonoscopy Bowel Preparation Quality on Follow-up Interval Recommendations for Average-risk Patients With Normal Screening Colonoscopies: Data From the New Hampshire Colonoscopy Registry
34. Assessing data availability and quality within an electronic health record system through external validation against an external clinical data source
35. What Do ‘False-Positive’ Stool Tests Really Mean? Data from the New Hampshire Colonoscopy Registry
36. Serrated Polyp Yield at Colonoscopy in Patients with Positive FIT, Positive mt-sDNA, and Colonoscopy Only: Data from the New Hampshire Colonoscopy Registry
37. The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
38. Abstract IA023: Therapeutic efficacy of trametinib and ganitumab in RAS-mutated rhabdomyosarcoma
39. Clinically significant serrated polyp detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry
40. Adenoma Detection Rates for Screening Colonoscopies in Smokers and Obese Adults: Data From the New Hampshire Colonoscopy Registry
41. Abstract 2152: TNIK, a novel activator of FAK and YAP signaling, is a therapeutic target in lung squamous cell carcinoma
42. IMPACT OF SERRATED POLYPS DETECTED DURING 1ST SURVEILLANCE EXAM ON OUTCOMES AT 2ND SURVEILLANCE COLONOSCOPY
43. Differences in Detection Rates of Adenomas and Serrated Polyps in Screening Versus Surveillance Colonoscopies, Based on the New Hampshire Colonoscopy Registry
44. Colorectal Neoplasia Detection in Individuals With Positive Multitarget Stool DNA Tests: Data From the New Hampshire Colonoscopy Registry.
45. Serrated Polyp Yield at Colonoscopy in Patients with Positive FIT, Positive mt-sDNA, and Colonoscopy Only: Data from the New Hampshire Colonoscopy Registry.
46. Colonoscopy Findings in FIT+ and mt-sDNA+ Patients versus in Colonoscopy-only Patients: New Hampshire Colonoscopy Registry Data
47. Colorectal Neoplasia Detection in Individuals With Positive Multitarget Stool DNA Tests
48. Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma
49. Translation of an efficacious cancer-screening intervention to women enrolled in a Medicaid managed care organization
50. TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.